LinkZill empowers life sciences with TFT semiconductor technology, creating the world’s first TFT-based DNA synthesizer alongside superior oligo microarrays and oligo pools. These products form a comprehensive business ecosystem spanning end-user devices, mass-produced chip consumables, and synthesis products, providing efficient synthesis solutions for companies and research institutions engaged in synthetic biology, high-throughput omics technologies, innovative drug discovery, medical diagnostics, and molecular breeding. Leveraging its proprietary TFT biochip platform, LinkZill aims to build fully integrated next-generation life science tools.